RetinalGenix Technologies (RTGN) Assets Growth (1y) (2021 - 2026)
RetinalGenix Technologies (RTGN) Assets Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -51.35% |
| Dec 31, 2025 | 40.78% |
| Sep 30, 2025 | -92.12% |
| Jun 30, 2025 | -90.36% |
| Mar 31, 2025 | -76.38% |
| Dec 31, 2024 | 9,480.77% |
| Sep 30, 2024 | 39,390.67% |
| Jun 30, 2024 | 4,006.61% |
| Mar 31, 2024 | 555.98% |
| Dec 31, 2023 | -46.94% |
| Sep 30, 2023 | -94.25% |
| Jun 30, 2023 | 7,748.15% |
| Mar 31, 2023 | 201.41% |
| Dec 31, 2022 | -94.06% |
| Sep 30, 2022 | -89.30% |
| Dec 31, 2021 | -91.90% |